Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Industry News

    Pandemic Influenza Vaccine Facility Dedication on Sept. 18

    By Global Biodefense StaffSeptember 15, 2014
    Texas A&M Logo
    Share
    Facebook LinkedIn Reddit Email

    Texas A&M will join the State of Texas, biopharmaceutical company GSK and the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) this week at a dedication ceremony for the new Pandemic Influenza Vaccine Facility (PIVF).

    The PIVF serves as the next milestone for the Texas A&M Center for Innovation in Advanced Development and Manufacturing (CIADM) in Bryan-College Station, one of three government-funded biodefense centers in the United States.

    The CIADM was founded on a $285 million public-private partnership between the U.S. Department of Health and Human Services, and collaborating academic, commercial and State of Texas stakeholders. The center is responding to the need for rapid and flexible manufacturing to bolster the nation’s response ability in the event of a public health threat, including naturally occurring emerging infectious diseases, as well as chemical, biological and nuclear hazards.

    The state-of-the-art PIVF facility is designed to supply bulk antigen to meet the U.S. Government requirements for 50 million doses of pandemic influenza vaccine within four month of a declared pandemic.

    The event will be held Thursday, September 18, 2014 at the facility’s site.

    Attendees for the event include Texas Governor Rick Perry; Robin Robinson, Ph.D., BARDA director and deputy assistant secretary for preparedness and response, U.S. Department of Health and Human Services; along with other representatives from the State of Texas, Texas A&M and GSK.

    The PIVF is on track for completion by the end of 2015.

    ASPR BARDA HHS Pandemic Vaccine News
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleRacing Ahead of Disease Outbreaks: $12M in Grants Awarded
    Next Article ECBC Protects Soldiers Against Lethal Chemical Attacks

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023

    Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve

    September 13, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.